Impact BioMedical Inc. (NYSE American: IBO)’s Post

Name: Impact BioMedical Inc. (NYSE American: IBO) on LinkedIn: ✨ ICYMI: Catch the Impact BioMedical (NYSE American: IBO) management team…
Uploaded: 2024-12-05T17:07:32.060Z
Duration: 3 min 45 s
Channel: Impact BioMedical Inc. (NYSE American: IBO)
Description: ✨ ICYMI: Catch the Impact BioMedical (NYSE American: IBO) management team as they delve into their four core platform technologies and explain how these align with the company’s unique business model! ✨ You can view the full live webinar hosted on November 20th here: https://lnkd.in/ewZ82H4s

Impact BioMedical Inc. (NYSE American: IBO)

293 followers

1mo Edited

✨ ICYMI: Catch the Impact BioMedical (NYSE American: IBO) management team as they delve into their four core platform technologies and explain how these align with the company’s unique business model! ✨ You can view the full live webinar hosted on November 20th here: https://lnkd.in/ewZ82H4s

Transcript

Mark, if you would help us with maybe going over what our platforms are? Sure, Frank Happy too. And that's been that's been a few minutes talking about those. So you know, it's actually one of the things that I think is really important to understand about impact Biomedical is our business model and how it relates to the platforms. Our purpose is to find, discover, look for the unique and new. And then prove and patent that to a point where it becomes an attractive asset to our partners as they look to build and grow their revenue and income. Of the four core platforms we have right, the first is linebacker. Linebacker is a Polyphenol biopharmaceutical platform in preclinical studies with potential application and oncology. Inflammatory disease and neurology. The current preclinical work is focused on solid tumors and oncology colon and lung. You are Partner Profits Laboratories, who's a public company traded on the NASDAQ exchange. Second platform is equal there. Aqua Veer is a unique. Flavonoid based technology can be applied as either an over the counter offering. As a health supplement or an over the counter cold and flu light treatment or as a prescription pharmaceutical for antiviral applications, Equal Virus partnered with Prophase and Prophase is completing the first human study of Ecuador and with positive results. We'll take that technology to market as a first product offering sometime here in the near future. In addition, Latos, Latos is a sugar based platform. It's a combination of inositol and a number of other sugars in different weights and combinations that can result in application and inflammatory or metabolic disease or as a health supplement to manage and help reduce overall glycemic index. Latos is currently available for partnering and we are in active. Discussions with a number of different companies regarding their interest. The final of the 4th platforms IS3F. We have per functional fragrance. It's terpene based, comes from a unique source in warm weather climates and can be applied either as a all natural insect repellent. Or as an antimicrobial coating on hard soft surfaces to also repel insect activity. 3F is also available for immediate partnering and we're very excited about the potential to talk more about those discussions in the near future. In addition, we continue to explore a number of other categories, natural preservatives, other biopharmaceuticals, indoor air quality. Resulting today in an intellectual property or patent platform of over 38 issued patents worldwide and an additional 50 pending. So for organizations looking to have near term options to bring new products and revenue in, we're very open to those conversations and look forward as they increase continually on the heels here of our public offer.

To view or add a comment, sign in

More Relevant Posts

BioSystems Philippines

129 followers
3mo
Report this post
Get ready to redefine solutions! 🧪✨ We're excited to announce our annual BioSystems End User Conference hybrid event! Join us as we explore innovative assays and technology that are shaping the future of clinical analysis. Stay tuned for more details on registration, speakers and program details. #BioSystems #EndUserConference #Innovation #ClinicalAnalysis #HumanCenteredBiotech"
Like Comment
To view or add a comment, sign in
ResearchHub

2,944 followers
1mo
Report this post
Today’s biomedical system fails to incentivize cures, but open markets could change everything. Watch the full presentation by Paul Kohlhaas, Founder of BIO: https://lnkd.in/ePcBYuPp
Like Comment
To view or add a comment, sign in
Caldwell

5,221 followers
6mo
Report this post
The femtech industry is expected to reach $103 billion by 2030. Motivated by an explosion of companies dedicated to disrupting a historically underserved space, femtech companies are collecting valuable insights to power future developments. Our Partner and Director of the Life Sciences Practice Group, Katherine Rubino, and our Associate, Kasia Zebrowska-Trauben, discussed IP considerations for this emerging market in Inc. Magazine, highlighting the value of developing a robust IP strategy to secure funding. As more and more femtech companies enter the market, leaders will need to establish business objectives early on to protect their transformative innovations and create the most successful IP strategies. Read more advice about the ways IP can protect innovative breakthroughs in life sciences from Kasia and Katherine in Inc.: https://lnkd.in/gGnpQQ_h
Like Comment
To view or add a comment, sign in
Today's Clinical Lab

2,617 followers
5mo
Report this post
Discover how to enhance diagnostic reliability and efficiency in your lab! Dive into our latest white paper on the novel LC-MS panel, sponsored by Tecan. Unlock the potential for faster, more accurate patient results. 📄 Read the full white paper here: https://bit.ly/4c0ytX6 #Diagnostics #LaboratoryScience #TECAN #ClinicalResearch #Innovation
Like Comment
To view or add a comment, sign in
MD+DI

3,945 followers
1mo
Report this post
🌟 Insights from MEDevice Silicon Valley! Elyse Blazevich, President & CEO of the Colorado BioScience Association, discusses the thriving medtech and life sciences sector in Colorado. Check it out! #MEDeviceSV #medtech #lifesciences
Like Comment
To view or add a comment, sign in
Colorado BioScience Association

9,533 followers
2w
Report this post
Elyse Blazevich, CBSA President and CEO, highlighted Colorado’s thriving life sciences ecosystem and medtech sector at MEDevice Silicon Valley 2024, an event dedicated to advancing medical device innovation. Elyse emphasized Colorado’s leadership in medtech innovation, showcasing how the state fosters a vibrant community that accelerates product development, ensures compliance, and drives market readiness. The expo brought together a diverse group of engineers, business leaders, technologists, cybersecurity experts, disruptive companies, and visionary thinkers, from startups to leading medical device OEMs. CBSA is proud to celebrate Colorado’s strong presence at this event and the opportunity to connect with industry leaders shaping life-changing healthcare innovations. https://lnkd.in/gCttaSVz #CoBioScience #StrongerTogether #AllIn

MD+DI

3,945 followers
1mo

🌟 Insights from MEDevice Silicon Valley! Elyse Blazevich, President & CEO of the Colorado BioScience Association, discusses the thriving medtech and life sciences sector in Colorado. Check it out! #MEDeviceSV #medtech #lifesciences
Like Comment
To view or add a comment, sign in
ELIXIR-IT

695 followers
1mo
Report this post
Maria Teresa Mancini from Masmec S.p.A. - Biomed division, talks about the new frontiers of laboratory automation: from processing to analysis. She emphasizes the need for collaboration in research and development to advance emerging diagnostic protocols and point-of-care solutions. #Diagnostics #Innovation #LabAutomation #Healthcare
Like Comment
To view or add a comment, sign in
Nick Rich
2mo
Report this post
If your operating in the innovation space for health and care delivery then you should check out the I opportunities to collaborate with Professor Chris Hopkins at Tritech!
🚀 Manish Patel
2mo

We've previously worked with the TriTech Institute and Prof. Chris Hopkins FAHCS, FIPEM, CSci, CEng to test and improve a medical diagnostic. I could not recommend this team enough - if you're in the diagnostics / health innovation space and looking to get a real world assesment of it, this is your ticket.
Like Comment
To view or add a comment, sign in
Curiox Biosystems

4,659 followers
3mo
Report this post
🎉 Exciting News! 🎉 Curiox will be at the International Clinical Cytometry Society (ICCS) meeting next week! Stop by Booth 300 to explore how our advanced solutions can transform your workflows with efficiency and precision. Whether you're interested in the Pluto system, our latest innovation, or learning about how we are advancing flow cytometry, we'd love to chat and answer any questions you may have! See you there at Booth 300! #FlowICCS24 #flowcytometry
1 Comment
Like Comment
To view or add a comment, sign in
YPrime

27,380 followers
3w
Report this post
Uncertainty in a hypothesis? That's part of science. Uncertainty in clinical research? YPrime solves for that. See how: https://hubs.ly/Q02_cwN_0 #eCOA #IRT #eConsent #ClinicalTrialTech #DigitalHealth #ClinicalResearch #ClinicalTrials
Like Comment
To view or add a comment, sign in

Impact BioMedical Inc. (NYSE American: IBO)

293 followers

View Profile Follow

Impact BioMedical Inc. (NYSE American: IBO)’s Post

Transcript

More Relevant Posts

Explore topics